Many organizations that strive to become data-driven ultimately struggle to get value from their data. Seemingly promising analytics proofs of concept fail to scale in production, technology platforms aren’t always fully mature, and driving real impact from data often requires fundamental changes to the way people work across a range of disciplines and functions.
For GlaxoSmithKline (GSK), a data strategy grounded in near-term priorities and value creation has proved key in avoiding such issues, enabling the pharmaceutical titan to establish the processes and technical foundation necessary to embrace bolder transformational moves aimed at competitive advantage. The strategy, launched in 2018 and dubbed Value Strikes, began bearing fruit in 2019 with a series of advanced analytics use cases, earning GSK a CIO 100 Award in IT Excellence.
Read More from This Article: GSK takes targeted approach to data-driven transformation